Found 36 matching trials
Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma PHASE2 This is a multicenter, phase 2, open label study to evaluate safety, tolera...
Show More Location
Harbin Medical University Cancer Hospital
Learn More & Join Trial
SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in HR Positive/HER2 Low Breast Cancer PHASE2 This is an open-label, phase II study evaluating the efficacy and safety of...
Show More Location
Shengjing Hospital affiliated to China Medical University
Learn More & Join Trial
A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors PHASE1 This study is an open, multicenter Phase I/II clinical trial, divided into ...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
A Study of SHR-A1811 in Subjects With Gynaecologic Oncology PHASE2 This is an open-label, two-part study to evaluate the safety and efficacy o...
Show More Location
Qilu Hospital of Shandong University
Learn More & Join Trial
A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer PHASE3 This study is a multicenter, randomized, open-label, parallel Phase III cli...
Show More Status
Active Not Recruiting
Location
Shengjing Hospital, China Medical University
Learn More & Join Trial
A Phase III Study of SHR-A1811 in Combination With Chemotherapy and Adebrelimab in Previously Untreated Patients With Gastric or Gastroesophageal Junction Adenocarcinoma PHASE3 This study aims to evaluate the efficacy and safety of SHR-A1811 combined w...
Show More Location
The First Hospital of China Medical University
Learn More & Join Trial
MA-CRC-II-016 SHR-1811 PHASE2 A randomized, controlled, multicenter clinical study of SHR-A1811 combined ...
Show More Location
Multiple Locations
Learn More & Join Trial
Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer PHASE2 The goal of this clinical trial is to learn if add SHR-A1811 and/or Adebrel...
Show More Location
National Cancer Center/Cancer hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer PHASE1 This is an open-label, two-part study to evaluate the safety, tolerability,...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
SHR-A1811 Versus Investigator's Chemotherapy in Recurrent/Metastatic Breast Cancer Clinical Trial PHASE3 The aim of this study was to evaluate whether the progression-free survival...
Show More Status
Active Not Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial